Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma.

Publication Year: 2024

DOI:
10.3389/fonc.2024.1304144

PMCID:
PMC10881812

PMID:
38390257

Journal Information

Full Title: Front Oncol

Abbreviation: Front Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The technology reported on here has been commercialized by ImpriMed, Inc. AC, JT, SP, SK, and SL are employees of ImpriMed. DS is an independent contractor for ImpriMed and KC is a consultant for ImpriMed."

Evidence found in paper:

"The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025